Matthew M. Gosling
2015
In 2015, Matthew M. Gosling earned a total compensation of $2M as Senior Vice President and General Counsel at DepoMed, a 42% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $268,637 |
|---|---|
| Option Awards | $585,047 |
| Salary | $441,577 |
| Stock Awards | $718,500 |
| Other | $8,686 |
| Total | $2,022,447 |
Gosling received $718.5K in stock awards, accounting for 36% of the total pay in 2015.
Gosling also received $268.6K in non-equity incentive plan, $585K in option awards, $441.6K in salary and $8.7K in other compensation.
Rankings
In 2015, Matthew M. Gosling's compensation ranked 4,687th out of 13,638 executives tracked by ExecPay. In other words, Gosling earned more than 65.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,687 out of 13,638 | 66th |
Division Manufacturing | 1,714 out of 5,190 | 67th |
Major group Chemicals And Allied Products | 616 out of 1,854 | 67th |
Industry group Drugs | 489 out of 1,528 | 68th |
Industry Pharmaceutical Preparations | 387 out of 1,182 | 67th |
Source: SEC filing on July 14, 2017.
Gosling's colleagues
We found four more compensation records of executives who worked with Matthew M. Gosling at DepoMed in 2015.